BioPharma Resources

Drug Trial Radar · NCT05930561

4D-150 in Patients With Diabetic Macular Edema

A Phase 2 Randomized, Active-Controlled, Double-masked Trial of Intravitreal 4D-150 Gene Therapy in Adults With Diabetic Macular Edema (SPECTRA)

Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Aug 9, 2023

Primary completion

Feb 28, 2029

Study completion Feb 28, 2029

Sponsor

Lead sponsor
4D Molecular TherapeuticsIndustry
Sponsor type
Industry
First posted
Jul 5, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).

Conditions

  • Diabetic Macular Edema
  • Diabetic Retinopathy

Interventions

  • 4D-150 IVTBiological

    4D-150: AAV-based gene therapy comprised of miRNA targeting VEGF-C and codon-optimized sequence encoding aflibercept.

  • Aflibercept IVTBiological

    Commercially available Active Comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and severity of TEAEs and SAEs, including clinically significant changes in safety parameters (Part 1)Time frame: 60 months
  2. Annualized number of aflibercept injections in the study eye (Part 2)Time frame: 52 weeks

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland

  • Verum Research, LLC

    Eugene, Oregon

  • Erie Retina Research

    Erie, Pennsylvania

  • Austin Clinical Research

    Austin, Texas

  • Piedmont Eye Center

    Lynchburg, Virginia

  • Emanuelli Research and Development Center

    Arecibo, Puerto Rico, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.